Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) recently announced the termination of its Exclusive Supply and Distribution Agreement with EMC Pharma, LLC (“EMC”) following EMC’s failure to meet minimum ...
BOULDER, CO / ACCESSWIRE / November 21, 2024 / (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for ...
Causes: Butterfly disease refers to a group of rare, inherited diseases that cause the skin to be very fragile and to blister easily. There are around 30 subtypes of butterfly disease, and these are ...
The acquisition of ProgenaMatrix and revyve Antimicrobial Wound Gel reflects the Company's continued commitment to building a diverse portfolio of complementary wound care products that enable BioStem ...
BioStem expects to finalize definitive agreements within 60 days following customary due diligence. The transaction is subject to regulatory approvals and Board consent. BioStem and ProgenaCare will ...
Research from Chalmers University of Technology, Sweden, shows that resistant bacteria can regain susceptibility to antibiotics when the treatment is combined with a material equipped with ...
During this autumn, a wound care dressing with the hydrogel is launched in eight different European countries, intended for veterinary use. An application for approval for a wound care dressing for ...